Abstract: The invention relates to novel polymers of benzodithiophene, methods and materials for their preparation, their use as semiconductors in organic electronic (OE) devices, and to OE devices comprising these polymers.

Abstract: The present invention provides compounds produced by the reaction of glycidyl ethers and glycidyl esters with ether compounds including N,N,N?-trimethyl-bis-(aminoethyl) ether. N,N,N?-trimethyl-bis-(aminoethyl) ether and its derivatives can be used as polyurethane catalysts.

Abstract: Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease.

Abstract: The invention relates to novel organic semiconducting compounds containing a polycyclic unit, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to the use of the compounds, compositions and polymer blends as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, PSC, OPD, OFET and OLED devices comprising these compounds, compositions or polymer blends.

Abstract: A time-to-digital converter (TDC) measures a time interval ?TTot between a leading signal and a triggering signal. A phase regulator incorporates a looped delay line to create pre-defined sub-intervals TNOR determined by the length of the delay line. The phase regulator has an input receiving the leading signal such that the leading signal loops around the delay line. A counter for counting the number of times m the leading signal loops around the delay line before said triggering signal arrives to obtain a coarse measurement of the time interval defined in terms of the sub-intervals TNOR. A Vernier core for measures a residual time interval TR where TR=?TTot?mTNOR to obtain a value for the time interval ?TTot. The TDC uses simpler encoding logic with reduced power consumption and phase noise performance better than 5 dB.

Abstract: Certain chemical entities are provided herein. Also provided are pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease. Also described are methods of treatment include administering at least one chemical entity as a single active agent or administering at least one chemical entity in combination with one or more other therapeutic agents. Also provided are methods for screening compounds capable of inhibiting KMO activity.

Abstract: A radio-frequency (RF) module includes a driver transistor having a base, collector and emitter, an RF input port coupled to the base of the driver transistor, a cascode transistor having a base, collector and emitter, the emitter of the cascode transistor being coupled to the collector of the driver transistor, an RF output port coupled to the collector of the cascode transistor, and a coupling path connecting the base of the cascode transistor to the emitter of the cascode transistor, the coupling path including a capacitor.

Abstract: The present invention relates to thiadiazolopyridine polymers, their synthesis and their use. The present invention further relates to organic electronic devices comprising such thiadiazolopyridine polymers.

Abstract: Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described; which comprise administering to such patients an amount of at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease.

Abstract: A lighting and fan combination device is disclosed where the lighting can be mounted on a housing of the fan. One or more light and fan combination members can be connected to a mount that allows the device to be mounted to a wall, ceiling, or other structure. The lighting component may be separable from the fan housing and can be interchanged with other types of lighting components. The lighting elements may be LEDs or other lighting elements.

Abstract: A time-to-digital converter (TDC) measures a time interval ?TTot between a leading signal and a triggering signal. A phase regulator incorporates a looped delay line to create pre-defined sub-intervals TNOR determined by the length of the delay line. The phase regulator has an input receiving the leading signal such that the leading signal loops around the delay line. A counter for counting the number of times m the leading signal loops around the delay line before said triggering signal arrives to obtain a coarse measurement of the time interval defined in terms of the sub-intervals TNOR. A Vernier core for measures a residual time interval TR where TR=?TTot?mTNOR to obtain a value for the time interval ?TTot. The TDC uses simpler encoding logic with reduced power consumption and phase noise performance better than 5 dB.

Abstract: The present invention relates compounds comprising a tetra-heteroaryl indacenodithiophene-based structural unit, the synthesis of such compounds as well as their use in organic electronic devices. The invention further relates to organic electronic devices comprising such compounds.

Abstract: A cascode power cell for a power amplifier circuit includes a radio frequency signal input node, a radio frequency signal output node, and a plurality of sub-cells each including a first transistor having a collector coupled to the radio frequency signal output node, each of the plurality of sub-cells further including a second transistor having a collector coupled to an emitter of the first transistor at a connection node, and a base coupled to the radio frequency signal input node, the connection nodes for each of the plurality of sub-cells being electrically isolated from one another.

Abstract: Circuits, devices and methods are disclosed, including a phase shifter configured to provide a bypass state, a single first-handed quarter-wave state, a double first-handed quarter-wave state, or a single second-handed quarter-wave state utilizing two or less inductors. In some implementations, a phase shifter is disclosed to provide a first node and a second node, a first switchable path having a first inductance and a second inductance arranged in series between the first and second nodes, a capacitive grounding path implemented on each side of each of the first and second inductances, at least one of the capacitive grounding paths configured as a switchable capacitive grounding path, and a reconfiguring circuit assembly configured to allow the phase shifter to provide a plurality of quadrant phase shifts utilizing the first and second inductances and the at least one switchable capacitive grounding path.

Abstract: Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one compound, or pharmaceutically acceptable salt or prodrug thereof, described herein effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease.

Abstract: The present invention provides compounds produced by the reaction of glycidyl ethers and glycidyl esters with ether compounds including N,N,N?-trimethyl-bis-(aminoethyl)ether. N,N,N?-trimethyl-bis-(aminoethyl)ether and its derivatives can be used as polyurethane catalysts.

Abstract: The invention relates to novel polymers containing repeating units based on benzo[2,1,3]thiadiazole-5,6-dicarboxylic acid bis-ester, monomers and methods for their preparation, their use as semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers.

Abstract: An apparatus for removal of an animal body part, the apparatus comprising a ligature applicator, the ligature applicator being configured to move a ligature between a first, extended state in which the ligature can be passed over the animal body part to a selected application position, and a second, retracted state in which the ligature applies a compressive force at the application position to restrict blood flow in the animal body part; and a substance applicator, the substance applicator being configured to deliver a substance to the animal.

Abstract: The invention relates to novel conjugated polymers containing one or more diindeno-thieno[3,2-b]thiophene based polycyclic repeating units, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these polymers, polymer blends, mixtures or formulations.

Abstract: Disclosed are circuits and method for reducing or eliminating reference spurs in frequency synthesizers. In some implementations, a phase-locked loop (PLL) such as a Frac-N PLL of a frequency synthesizer can include a phase frequency detector (PFD) configured to receive a reference signal and a feedback signal. The PFD can be configured to generate a first signal representative of a phase difference between the reference signal and the feedback signal. The PLL can further include a compensation circuit configured to generate a compensation signal based on the first signal. The PLL can further includes a voltage-controlled oscillator (VCO) configured to generate an output signal based on the compensation signal. The compensation signal can include at least one feature for substantially eliminating one or more reference spurs associated with the PLL.